Efficacy of Acupuncture Combined With Moxibustion for HUA: A Randomized Controlled Trial
International Journal of Clinical Practice · 2026-01 · 2026 (1)
DOI: 10.1155/ijcp/7877206 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Clinical Practice, online erschienen am 02.08.2026. Verfasst von Chinn En Goh und 7 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Objective
This study aimed to evaluate the efficacy of acupuncture combined with moxibustion in hyperuricemia (HUA) patients and to explore its influence on serum uric acid (SUA) and related metabolic indicators.
Methods
This study was a randomized controlled trial. Seventy individuals diagnosed with HUA were randomly assigned in equal numbers to a treatment group and a control group. Both groups received standardized health education, while the treatment group additionally underwent acupuncture and moxibustion. Acupuncture was applied at Zhongwan (CV12), Daheng (LR17), Tianshu (ST25), Guanyuan (CV4), Zusanli (ST36), Yinlingquan (SP9), Sanyinjiao (SP6), Fenglong (ST40), and Taixi (KI3) for 30 min per session, three times weekly. Moxibustion was performed at Pishu (BL20) and Shenshu (BL23) for 20 min per session, three times weekly. The intervention lasted four weeks. SUA served as the primary endpoint, whereas secondary indicators comprised total cholesterol (TC), triglycerides (TG), low‐density lipoprotein cholesterol (LDL‐C), fasting blood glucose, and body mass index (BMI).
Results
Sixty‐two participants completed the study (31 per group). After treatment, SUA levels significantly declined in both groups ( p < 0.01), with a greater reduction observed in the treatment group ( p = 0.011). The treatment group also exhibited significant decreases in TC, TG, LDL‐C, and fasting glucose compared with baseline ( p < 0.01). Between‐group differences were significant for TC and glucose ( p < 0.05). BMI declined notably in both groups, though intergroup differences were not significant ( p > 0.05). There were no reports of serious or unexpected adverse reactions among participants. Minor local hematomas ( n = 3) and transient skin irritation after moxibustion ( n = 1) resolved spontaneously.
Conclusions
Acupuncture combined with moxibustion presents a promising and safe nonpharmacological approach for managing HUA. In this preliminary 4‐week trial, it significantly lowered SUA levels and showed potential in modulating key metabolic indicators like TC and glucose, though larger, long‐term trials are required to firmly establish its efficacy in complication prevention. Trial Registration: International Traditional Medicine Clinical Trial Registry: ITMCTR2025002106
Förderung
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Goh, C. E., Tao, L., Hu, C., Chen, A., Zhang, K., Chen, Z., Shen, W., & Li, D. (2026). Efficacy of Acupuncture Combined With Moxibustion for HUA: A Randomized Controlled Trial. International Journal of Clinical Practice, 2026(1). https://doi.org/10.1155/ijcp/7877206
Vancouver
Goh CE, Tao L, Hu C, Chen A, Zhang K, Chen Z, et al. Efficacy of Acupuncture Combined With Moxibustion for HUA: A Randomized Controlled Trial. International Journal of Clinical Practice. 2026;2026(1). doi:10.1155/ijcp/7877206
BibTeX
@article{Goh2026,
author = {Goh, Chinn En and Tao, Larissa and Hu, Chen and Chen, Aiwen and Zhang, Kun and Chen, Zihe and Shen, Weidong and Li, Dong},
title = {Efficacy of Acupuncture Combined With Moxibustion for HUA: A Randomized Controlled Trial},
journal = {International Journal of Clinical Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijcp/7877206}
}
EUVIMED